JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Smith & Nephew PLC ADR

Закрыт

33.73 -0.91

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

33.55

Макс.

34.04

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

30.423

90.422

Дивидендная доходность

2.26

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+2.04% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.26%

2.13%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

34.64

Предыдущая цена закрытия

33.73

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

28 янв. 2026 г., 23:51 UTC

Отчет

Correction to Samsung Fourth-Quarter Net Profit Article

28 янв. 2026 г., 23:49 UTC

Популярные акции

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 янв. 2026 г., 23:19 UTC

Отчет

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 янв. 2026 г., 22:43 UTC

Отчет

Waste Management Logs Higher 4Q Profit as Revenue Rises

29 янв. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29 янв. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29 янв. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29 янв. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28 янв. 2026 г., 23:49 UTC

Обсуждения рынка

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 янв. 2026 г., 23:30 UTC

Обсуждения рынка

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 янв. 2026 г., 23:28 UTC

Отчет

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 янв. 2026 г., 23:26 UTC

Отчет

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 янв. 2026 г., 23:21 UTC

Отчет

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 янв. 2026 г., 23:18 UTC

Отчет
Приобретения, слияния, поглощения

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 янв. 2026 г., 22:58 UTC

Отчет

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 янв. 2026 г., 22:48 UTC

Обсуждения рынка

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 янв. 2026 г., 22:45 UTC

Отчет

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 янв. 2026 г., 22:44 UTC

Отчет

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 янв. 2026 г., 22:43 UTC

Отчет

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 янв. 2026 г., 22:41 UTC

Отчет
Популярные акции

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 янв. 2026 г., 22:41 UTC

Обсуждения рынка

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 янв. 2026 г., 22:41 UTC

Отчет

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 янв. 2026 г., 22:40 UTC

Отчет

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 янв. 2026 г., 22:39 UTC

Отчет

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 янв. 2026 г., 22:38 UTC

Отчет

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 янв. 2026 г., 22:37 UTC

Отчет

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 янв. 2026 г., 22:35 UTC

Отчет

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 янв. 2026 г., 22:26 UTC

Обсуждения рынка
Отчет

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 янв. 2026 г., 22:20 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

28 янв. 2026 г., 22:20 UTC

Обсуждения рынка

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

2.04% рост

Прогноз на 12 месяцев

Средняя 34.46 USD  2.04%

Максимум 34.91 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat